OPXS 10-Q Quarterly Report June 30, 2024 | Alphaminr
Optex Systems Holdings Inc

OPXS 10-Q Quarter ended June 30, 2024

OPTEX SYSTEMS HOLDINGS INC
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
false Q3 --10-01 0001397016 0001397016 2023-10-02 2024-06-30 0001397016 2024-08-13 0001397016 2024-06-30 0001397016 2023-10-01 0001397016 2024-04-01 2024-06-30 0001397016 2023-04-03 2023-07-02 0001397016 2022-10-03 2023-07-02 0001397016 2022-10-02 0001397016 2023-07-02 0001397016 us-gaap:CommonStockMember 2024-03-31 0001397016 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001397016 us-gaap:RetainedEarningsMember 2024-03-31 0001397016 2024-03-31 0001397016 us-gaap:CommonStockMember 2023-04-02 0001397016 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 0001397016 us-gaap:RetainedEarningsMember 2023-04-02 0001397016 2023-04-02 0001397016 us-gaap:CommonStockMember 2023-10-01 0001397016 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 0001397016 us-gaap:RetainedEarningsMember 2023-10-01 0001397016 us-gaap:CommonStockMember 2022-10-02 0001397016 us-gaap:AdditionalPaidInCapitalMember 2022-10-02 0001397016 us-gaap:RetainedEarningsMember 2022-10-02 0001397016 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001397016 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001397016 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001397016 us-gaap:CommonStockMember 2023-04-03 2023-07-02 0001397016 us-gaap:AdditionalPaidInCapitalMember 2023-04-03 2023-07-02 0001397016 us-gaap:RetainedEarningsMember 2023-04-03 2023-07-02 0001397016 us-gaap:CommonStockMember 2023-10-02 2024-06-30 0001397016 us-gaap:AdditionalPaidInCapitalMember 2023-10-02 2024-06-30 0001397016 us-gaap:RetainedEarningsMember 2023-10-02 2024-06-30 0001397016 us-gaap:CommonStockMember 2022-10-03 2023-07-02 0001397016 us-gaap:AdditionalPaidInCapitalMember 2022-10-03 2023-07-02 0001397016 us-gaap:RetainedEarningsMember 2022-10-03 2023-07-02 0001397016 us-gaap:CommonStockMember 2024-06-30 0001397016 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001397016 us-gaap:RetainedEarningsMember 2024-06-30 0001397016 us-gaap:CommonStockMember 2023-07-02 0001397016 us-gaap:AdditionalPaidInCapitalMember 2023-07-02 0001397016 us-gaap:RetainedEarningsMember 2023-07-02 0001397016 OPXS:USGovernmentMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:USDefenseContractorOneMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:USDefenseContractorTwoMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:USDefenseContractorThreeMember 2023-10-02 2024-06-30 0001397016 OPXS:OneMajorCommercialCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:AllOtherCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 country:US us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember OPXS:ForeignCustomersMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:USGovernmentAgenciesMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:MajorUSDefenseContractorOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:MajorUSDefenseContractorTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:MajorUSDefenseContractorThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:MajorUSDefenseContractorFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:MajorUSDefenseContractorFiveMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:OneCommercialCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:AllOtherCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 us-gaap:TransferredOverTimeMember 2024-04-01 2024-06-30 0001397016 us-gaap:TransferredOverTimeMember 2023-10-02 2024-06-30 0001397016 us-gaap:TransferredOverTimeMember 2023-04-03 2023-07-02 0001397016 us-gaap:TransferredOverTimeMember 2022-10-03 2023-07-02 0001397016 2022-11-30 0001397016 OPXS:OptexSystemsIncMember 2024-06-30 0001397016 OPXS:OptexSystemsIncMember 2023-10-01 0001397016 OPXS:UnvestedRectrictedStockMember 2024-04-01 2024-06-30 0001397016 OPXS:UnvestedRectrictedStockMember 2023-10-02 2024-06-30 0001397016 OPXS:UnvestedRectrictedStockUnitsMember 2024-04-01 2024-06-30 0001397016 OPXS:UnvestedRectrictedStockUnitsMember 2023-10-02 2024-06-30 0001397016 OPXS:UnvestedRectrictedStockMember 2023-04-03 2023-07-02 0001397016 OPXS:UnvestedRectrictedStockMember 2022-10-03 2023-07-02 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:SubcontractedCustomersMember OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:OptexRichardsonTexasMember OPXS:CommercialCustomersMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:DomesticMilitaryCustomersMember OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:ForeignMilitaryCustomersMember OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:USDefenseContractorOneMember OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:USGovernmentMember OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:AllOtherCustomersMember OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 OPXS:OptexRichardsonTexasMember 2024-06-30 0001397016 OPXS:OptexRichardsonTexasMember 2023-10-02 2024-06-30 0001397016 OPXS:CommercialCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:AppliedOpticsCenterAOCDallasMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:SubcontractedCustomersMember 2023-10-02 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember OPXS:IntersegmentSalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:MilitaryContractsMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:AllOtherCustomersMember 2023-10-02 2024-03-31 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:MajorUSDefenseContractorOneMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:MajorUSDefenseContractorTwoMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:OneCommercialCustomersMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPXS:AllOtherCustomersMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember 2023-10-02 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2024-04-01 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2024-04-01 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001397016 us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2024-04-01 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2023-04-03 2023-07-02 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2023-04-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2023-04-03 2023-07-02 0001397016 us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2023-04-03 2023-07-02 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2023-10-02 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2023-10-02 2024-06-30 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2023-10-02 2024-06-30 0001397016 us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2023-10-02 2024-06-30 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 OPXS:RevenuesFromExternalCustomersMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2022-10-03 2023-07-02 0001397016 OPXS:RevenuesFromExternalCustomersMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2022-10-03 2023-07-02 0001397016 OPXS:IntersegmentRevenuesMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 OPXS:OptexRichardsonTexasMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 OPXS:AppliedOpticsCenterAOCDallasMember us-gaap:OperatingSegmentsMember 2022-10-03 2023-07-02 0001397016 us-gaap:IntersegmentEliminationMember OPXS:OtherMember 2022-10-03 2023-07-02 0001397016 OPXS:OneNonCancellableOfficeEquipmentLeaseMember 2023-10-02 2024-06-30 0001397016 OPXS:OneNonCancellableOfficeEquipmentLeaseMember 2024-06-30 0001397016 us-gaap:OfficeEquipmentMember 2022-10-02 0001397016 OPXS:FacilityLeaseAgreementMember 2024-04-01 2024-06-30 0001397016 OPXS:FacilityLeaseAgreementMember 2023-04-03 2023-07-02 0001397016 OPXS:FacilityLeaseAgreementMember 2023-10-02 2024-06-30 0001397016 OPXS:FacilityLeaseAgreementMember 2022-10-03 2023-07-02 0001397016 OPXS:OptexSystemsOPXRichardsonTexasMember 2024-06-30 0001397016 OPXS:OfficeEquipmentLeaseMember 2024-06-30 0001397016 OPXS:CommonAreaMaintenanceEstimateMember 2024-06-30 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:BBVAMember 2020-04-15 2020-04-16 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:BBVAMember 2022-04-10 2022-04-12 0001397016 us-gaap:RevolvingCreditFacilityMember 2022-11-20 2022-11-20 0001397016 us-gaap:RevolvingCreditFacilityMember 2022-11-21 2022-11-21 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:TexasCapitalBankMember 2023-03-20 2023-03-22 0001397016 us-gaap:RevolvingCreditFacilityMember 2023-03-20 2023-03-22 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:TexasCapitalBankMember 2024-06-30 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:TexasCapitalBankMember 2023-03-22 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:TexasCapitalFacilityMember 2024-06-30 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:TexasCapitalFacilityMember 2024-04-01 2024-06-30 0001397016 us-gaap:RevolvingCreditFacilityMember OPXS:TexasCapitalFacilityMember 2023-10-03 2024-06-30 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2022-10-02 0001397016 us-gaap:RestrictedStockMember 2022-10-02 0001397016 us-gaap:PerformanceSharesMember 2022-10-02 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2022-10-03 2023-10-01 0001397016 us-gaap:RestrictedStockMember 2022-10-03 2023-10-01 0001397016 us-gaap:PerformanceSharesMember 2022-10-03 2023-10-01 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2023-10-01 0001397016 us-gaap:RestrictedStockMember 2023-10-01 0001397016 us-gaap:PerformanceSharesMember 2023-10-01 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2023-10-02 2024-06-30 0001397016 us-gaap:RestrictedStockMember 2023-10-02 2024-06-30 0001397016 us-gaap:PerformanceSharesMember 2023-10-02 2024-06-30 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2024-06-30 0001397016 us-gaap:RestrictedStockMember 2024-06-30 0001397016 us-gaap:PerformanceSharesMember 2024-06-30 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember srt:ChiefExecutiveOfficerMember 2018-12-28 2019-01-02 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember srt:ChiefFinancialOfficerMember 2018-12-28 2019-01-02 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember OPXS:BillBatesMember 2018-12-28 2019-01-02 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember OPXS:BillGatesMember 2018-12-28 2019-01-02 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember OPXS:BillGatesMember 2019-01-02 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember OPXS:BillBatesMember 2020-02-16 2020-02-17 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember OPXS:BillGatesMember 2020-02-16 2020-02-17 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember OPXS:BillBatesMember 2020-02-17 0001397016 OPXS:ThreeIndependentDirectorsMember 2020-04-29 2020-04-29 0001397016 OPXS:ThreeIndependentDirectorsMember 2020-04-30 2020-04-30 0001397016 OPXS:ThreeIndependentDirectorsMember 2020-04-29 2020-04-30 0001397016 OPXS:ThreeIndependentDirectorsMember 2020-04-30 0001397016 srt:DirectorMember 2022-01-01 2022-01-01 0001397016 2023-02-16 0001397016 OPXS:EmploymentAgreementMember 2021-12-01 2021-12-01 0001397016 OPXS:TwoThousandSixteenRestrictedStockUnitPlanMember 2021-12-01 0001397016 srt:ChiefExecutiveOfficerMember 2023-01-03 2023-01-04 0001397016 OPXS:ElevenEmployeesMember OPXS:TwoThousandTwentyThreeEquityIncentivePlanMember 2023-04-30 2023-05-01 0001397016 us-gaap:RestrictedStockUnitsRSUMember OPXS:OneNewEmployeeMember 2023-08-14 2023-08-14 0001397016 OPXS:TwoThousandTwentyThreeEquityIncentivePlanMember OPXS:ElevenEmployeesMember 2023-08-14 2023-08-14 0001397016 OPXS:TwoThousandTwentyThreeEquityIncentivePlanMember OPXS:ElevenEmployeesMember 2024-06-30 0001397016 OPXS:TwoThousandTwentyThreeEquityIncentivePlanMember OPXS:ElevenEmployeesMember 2023-10-01 0001397016 srt:ChiefExecutiveOfficerMember 2023-05-02 2023-05-03 0001397016 srt:ChiefFinancialOfficerMember 2023-05-02 2023-05-03 0001397016 us-gaap:CommonStockMember 2023-05-02 2023-05-03 0001397016 2023-05-02 2023-05-03 0001397016 OPXS:IndependentBoardMember 2023-05-08 2023-05-09 0001397016 OPXS:IndependentBoardMember srt:ScenarioForecastMember 2025-01-01 2025-01-01 0001397016 OPXS:IndependentBoardMember 2024-01-01 2024-01-01 0001397016 2023-05-09 2023-05-09 0001397016 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-10-02 2023-10-02 0001397016 us-gaap:PerformanceSharesMember 2023-10-24 2023-10-24 0001397016 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-12-22 2023-12-22 0001397016 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-29 2023-12-29 0001397016 us-gaap:PerformanceSharesMember 2024-01-08 2024-01-08 0001397016 us-gaap:PerformanceSharesMember 2023-12-22 2023-12-22 0001397016 us-gaap:PerformanceSharesMember OPXS:ShareBasedCompensationAwardTrancheFourMember 2024-03-11 2024-03-11 0001397016 us-gaap:PerformanceSharesMember 2024-03-13 2024-03-13 0001397016 OPXS:ElevenEmployeesMember OPXS:TwoThousandTwentyThreeEquityIncentivePlanMember 2024-05-01 2024-05-01 0001397016 us-gaap:RestrictedStockUnitsRSUMember OPXS:OneNewEmployeeMember 2024-06-04 2024-06-04 0001397016 OPXS:TwoThousandTwentyThreeEquityIncentivePlanMember OPXS:ElevenEmployeesMember 2024-06-04 2024-06-04 0001397016 OPXS:TwoThousandTwentyThreeEquityIncentivePlanMember 2024-04-30 2024-05-01 0001397016 OPXS:TenEmployeesMember 2024-05-03 0001397016 OPXS:TenEmployeesMember 2024-05-03 2024-05-03 0001397016 us-gaap:PerformanceSharesMember OPXS:ShareBasedCompensationAwardTrancheFiveMember 2024-05-17 2024-05-17 0001397016 us-gaap:PerformanceSharesMember 2024-05-17 2024-05-17 0001397016 us-gaap:PerformanceSharesMember 2024-06-30 2024-06-30 0001397016 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-10-02 2024-06-30 0001397016 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-10-02 2024-06-30 0001397016 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-10-02 2024-06-30 0001397016 OPXS:ShareBasedCompensationAwardTrancheFourMember 2023-10-02 2024-06-30 0001397016 OPXS:ShareBasedCompensationAwardTrancheFiveMember 2023-10-02 2024-06-30 0001397016 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-06-30 0001397016 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2024-06-30 0001397016 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2024-06-30 0001397016 OPXS:ShareBasedCompensationAwardTrancheFourMember 2024-06-30 0001397016 OPXS:ShareBasedCompensationAwardTrancheFiveMember 2024-06-30 0001397016 us-gaap:RestrictedStockMember 2024-04-01 2024-06-30 0001397016 us-gaap:RestrictedStockMember 2023-04-03 2023-07-02 0001397016 us-gaap:RestrictedStockMember 2022-10-03 2023-07-02 0001397016 us-gaap:PerformanceSharesMember 2024-04-01 2024-06-30 0001397016 us-gaap:PerformanceSharesMember 2023-04-03 2023-07-02 0001397016 us-gaap:PerformanceSharesMember 2022-10-03 2023-07-02 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2023-04-03 2023-07-02 0001397016 us-gaap:RestrictedStockUnitsRSUMember 2022-10-03 2023-07-02 0001397016 2024-01-18 2024-01-18 0001397016 2024-01-18 0001397016 OPXS:StockRepurchasePlanMember 2021-09-22 0001397016 us-gaap:CommonStockMember 2023-05-02 2023-07-02 0001397016 us-gaap:CommonStockMember 2023-03-01 2023-07-02 0001397016 OPXS:DannySchoeningMember 2024-04-01 2024-06-30 0001397016 OPXS:DannySchoeningMember 2023-10-02 2024-06-30 0001397016 OPXS:KarenHawkinsMember 2024-04-01 2024-06-30 0001397016 OPXS:KarenHawkinsMember 2023-10-02 2024-06-30 0001397016 OPXS:DannySchoeningMember us-gaap:PerformanceSharesMember 2024-04-01 2024-06-30 0001397016 OPXS:DannySchoeningMember us-gaap:PerformanceSharesMember 2023-10-02 2024-06-30 0001397016 OPXS:KarenHawkinsMember us-gaap:PerformanceSharesMember 2024-04-01 2024-06-30 0001397016 OPXS:KarenHawkinsMember us-gaap:PerformanceSharesMember 2023-10-02 2024-06-30 0001397016 OPXS:TenEmployeesMember 2024-04-01 2024-06-30 0001397016 OPXS:TenEmployeesMember 2023-10-02 2024-06-30 0001397016 OPXS:TenEmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0001397016 OPXS:TenEmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2023-10-02 2024-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure OPXS:Integer utr:sqft

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______to______.

OPTEX SYSTEMS HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware 001-41644 90-0609531

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

1420 Presidential Drive , Richardson , TX 75081-2439
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (972) 764-5700

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 par value OPXS The Nasdaq Stock Market LLC

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer Smaller Reporting Company

Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes ☐ No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of August 13, 2024: 6,873,234 shares of common stock.

OPTEX SYSTEMS HOLDINGS, INC.

FORM 10-Q

For the period ended June 30, 2024

INDEX

PART I— FINANCIAL INFORMATION F-1
Item 1. Unaudited Condensed Consolidated Financial Statements F-1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 1
Item 3. Quantitative and Qualitative Disclosures About Market Risk 13
Item 4. Controls and Procedures 13
PART II— OTHER INFORMATION 13
Item 1. Legal Proceedings 13
Item 1A. Risk Factors 13
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 13
Item 3. Defaults Upon Senior Securities 13
Item 4. Mine Safety Disclosures 13
Item 6. Exhibits 14
SIGNATURE 15

Part 1. Financial Information

Item 1. Unaudited Condensed Consolidated Financial Statements

OPTEX SYSTEMS HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2024 (UNAUDITED) AND OCTOBER 1, 2023 F-2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2024 (UNAUDITED) AND THE THREE AND NINE MONTHS ENDED JULY 2, 2023 (UNAUDITED) F-3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED JUNE 30, 2024 (UNAUDITED) AND THE NINE MONTHS ENDED JULY 2, 2023 (UNAUDITED) F-4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2024 (UNAUDITED) AND FOR THE THREE AND NINE MONTHS ENDED JULY 2, 2023 (UNAUDITED) F-5
CONDENSED CONSOLIDATED FINANCIAL STATEMENT FOOTNOTES (UNAUDITED) F-6

F- 1

Optex Systems Holdings, Inc.

Condensed Consolidated Balance Sheets

June 30, 2024 October 1, 2023
(Thousands, except share and per share data)
June 30, 2024 October 1, 2023
(Unaudited)
ASSETS
Cash and Cash Equivalents $ 486 $ 1,204
Accounts Receivable, Net 3,321 3,624
Inventory, Net 15,118 12,153
Contract Asset 237 336
Prepaid Expenses 316 219
Current Assets 19,478 17,536
Property and Equipment, Net 1,192 998
Other Assets
Deferred Tax Asset 838 922
Intangible Assets, Net 969 -
Right-of-use Asset 2,362 2,740
Security Deposits 23 23
Other Assets 4,192 3,685
Total Assets $ 24,862 $ 22,219
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts Payable $ 1,709 $ 810
Credit Facility 1,000 -
Operating Lease Liability 634 620
Federal Income Taxes Payable - 247
Accrued Expenses 1,187 1,265
Accrued Selling Expense 250 336
Accrued Warranty Costs 36 75
Contract Loss Reserves 101 243
Customer Advance Deposits 320 481
Current Liabilities 5,237 4,077
Other Liabilities
Credit Facility-Long Term

-

1,000

Operating Lease Liability, net of current portion 1,894 2,282
Other Liabilities 1,894 3,282
Total Liabilities 7,131 7,359
Commitments and Contingencies - -
Stockholders’ Equity
Common Stock – ($ 0.001 par, 2,000,000,000 authorized, 6,873,234 and 6,763,070 shares issued and outstanding, respectively) 7 7
Additional Paid in Capital 21,402 21,285
Accumulated Deficit ( 3,678 ) ( 6,432 )
Stockholders’ Equity 17,731 14,860
Total Liabilities and Stockholders’ Equity $ 24,862 $ 22,219

The accompanying notes are an integral part of these condensed consolidated financial statements

F- 2

Optex Systems Holdings, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

June 30, 2024 July 2, 2023 June 30, 2024 July 2, 2023
(Thousands, except share and per share data)
Three months ended Nine months ended
June 30, 2024 July 2, 2023 June 30, 2024 July 2, 2023
Revenue $ 9,060 $ 7,172 $ 24,552 $ 17,582
Cost of Sales 6,179 5,460 17,430 13,599
Gross Profit 2,881 1,712 7,122 3,983
General and Administrative Expense 1,266 960 3,599 2,897
Operating Income 1,615 752 3,523 1,086
Interest Expense 17 22 32 31
Income Before Taxes 1,598 730 3,491 1,055
Income Tax Expense 337 154 737 223
Net Income $ 1,261 $ 576 $ 2,754 $ 832
Basic income per share $ 0.19 $ 0.09 $ 0.41 $ 0.13
Weighted Average Common Shares Outstanding - basic 6,799,807 6,643,070 6,744,997 6,607,593
Diluted income per share $ 0.18 $ 0.09 $ 0.40 $ 0.13
Weighted Average Common Shares Outstanding – diluted 6,888,208 6,686,211 6,812,431 6,642,604

The accompanying notes are an integral part of these condensed consolidated financial statements

F- 3

Optex Systems Holdings, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

June 30, 2024 July 2, 2023

(Thousands)

Nine months ended

June 30, 2024 July 2, 2023
Cash Flows from Operating Activities:
Net Income $ 2,754 $ 832
Adjustments to Reconcile Net Income to Net Cash provided by (used in) Operating Activities:
Depreciation and Amortization 341 252
Stock Compensation Expense 360 134
Changes in Deferred Tax Expense 84 180
Accounts Receivable 303 38
Inventory ( 2,965 ) ( 3,070 )
Contract Asset 100 ( 336 )
Prepaid Expenses ( 97 ) ( 103 )
Leases 4 17
Accounts Payable and Accrued Expenses 820 914
Federal Income Taxes Payable ( 247 ) ( 331 )
Accrued Warranty Costs ( 39 ) 72
Accrued Selling Expense ( 86 ) 336
Customer Advance Deposits ( 161 ) ( 180 )
Accrued Loss Reserves ( 143 ) ( 156 )
Total Adjustments ( 1,726 ) ( 2,233 )
Net Cash provided by (used in) Operating Activities 1,028 ( 1,401 )
Cash Flows used in Investing Activities
Purchases of Intangible Assets ( 1,030 ) -
Purchases of Property and Equipment ( 473 ) ( 368 )
Net Cash used in Investing Activities ( 1,503 ) ( 368 )
Cash Flows (used in) provided by Financing Activities
Borrowing from Credit Facility 1,000 1,507
Payments to Credit Facility ( 1,000 ) ( 300 )
Cash Paid for Taxes Withheld on Net Settled Restricted Stock Unit Shares Issued ( 243 ) ( 58 )
Net Cash (used in) provided by Financing Activities ( 243 ) 1,149
Net Decrease in Cash and Cash Equivalents ( 718 ) ( 620 )
Cash and Cash Equivalents at Beginning of Period 1,204 934
Cash and Cash Equivalents at End of Period $ 486 $ 314
Supplemental Cash Flow Information:
Cash Transactions:
Cash Paid for Taxes 994 553
Cash Paid for Interest 26 28

The accompanying notes are an integral part of these condensed consolidated financial statements

F- 4

Optex Systems Holdings, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Thousands, except share data)

Shares Common Paid in Accumulated Stockholders
Three months ended June 30, 2024
Common Additional Total
Shares Common Paid in Accumulated Stockholders
Issued Stock Capital Deficit Equity
Balance at March 31, 2024 6,844,362 $ 7 $ 21,391 $ ( 4,939 ) $ 16,459
Stock Compensation Expense - - 90 - 90
Vested restricted stock units issued net of tax withholding 28,872 - ( 79 ) - ( 79 )
Net Income - - - 1,261 1,261
Balance at June 30, 2024 6,873,234 $ 7 $ 21,402 $ ( 3,678 ) $ 17,731

Three months ended July 2, 2023
Common Additional Total
Shares Common Paid in Accumulated Stockholders
Issued Stock Capital Deficit Equity
Balance at April 2, 2023 6,723,070 $ 7 $ 21,091 $ ( 8,439 ) $ 12,659
Stock Compensation Expense - - 81 - 81
Restricted/Unvested Shares Issued (2) 40,000 - - - -
Net Income - - - 576 576
Balance at July 2, 2023 6,763,070 $ 7 $ 21,172 $ ( 7,863 ) $ 13,316

Nine months ended June 30, 2024
Common Additional Total
Shares Common Paid in Accumulated Stockholders
Issued Stock Capital Deficit Equity
Balance at October 1, 2023 6,763,070 $ 7 $ 21,285 $ ( 6,432 ) $ 14,860
Stock Compensation Expense - - 360 - 360
Vested restricted stock units issued net of tax withholding 110,164 - ( 243 ) - ( 243 )
Net Income - - - 2,754 2,754
Balance at June 30, 2024 6,873,234 $ 7 $ 21,402 $ ( 3,678 ) $ 17,731

Nine months ended July 2, 2023
Common Additional Total
Shares Common Paid in Accumulated Stockholders
Issued Stock Capital Deficit Equity
Balance at October 2, 2022 6,716,638 $ 7 $ 21,096 $ ( 8,695 ) $ 12,408
Stock Compensation Expense - - 134 - 134
Taxes on Shares Issued for Vested Restricted Stock Units 46,432 - ( 58 ) - ( 58 )
Unvested Shares Forfeited (1) ( 40,000 ) - - - -
Restricted/Unvested Shares Issued (2) 40,000 - - - -
Net Income - - - 832 832
Balance at July 2, 2023 6,763,070 $ 7 $ 21,172 $ ( 7,863 ) $ 13,316

(1) Unvested common restricted shares which were forfeited and cancelled in February 2023.
(2) Restricted and unvested shares issued to board member on May 9, 2023. Shares vested 50 % January 1, 2024 and will vest 50% January 1, 2025 .

The accompanying notes are an integral part of these condensed consolidated financial statements

F- 5

Note 1 - Organization and Operations

Optex Systems Holdings, Inc. (together with its subsidiaries, the “Company,” “Optex Systems Holdings,” “we,” “us,” and “our”) manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications and commercial markets. Its products are installed on a variety of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and advanced security vehicles, and have been selected for installation on the Stryker family of vehicles. The Company also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex Systems Holdings’ products consist primarily of build to customer print products that are delivered both directly to the military and to other defense prime contractors or commercial customers. The Company’s consolidated revenues for the nine months ended June 30, 2024 were derived from the U.S. government ( 19 %), three major U.S. defense contractors ( 24 %, 8 %, and 7 %, respectively), one major commercial customer ( 15 %) and all other customers ( 27 %). Approximately 94 % of the total company revenue is generated from domestic customers and 6 % is derived from foreign customers, primarily in Canada and Israel. Optex Systems Holdings’ operations are based in Dallas and Richardson, Texas in leased facilities comprising 93,967 square feet. As of June 30, 2024, Optex Systems Holdings operated with 122 full-time equivalent employees.

Note 2 - Accounting Policies

Basis of Presentation

Principles of Consolidation : The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Optex Systems, Inc. All significant inter-company balances and transactions have been eliminated in consolidation.

The condensed consolidated financial statements of Optex Systems Holdings included herein have been prepared by Optex Systems Holdings, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in conjunction with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading.

These condensed consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and the notes thereto included in the Optex Systems Holdings’ Form 10-K for the year ended October 1, 2023 and other reports filed with the SEC.

The accompanying unaudited interim condensed consolidated financial statements reflect all adjustments of a normal and recurring nature which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows of Optex Systems Holdings for the interim periods presented. The results of operations for these periods are not necessarily comparable to, or indicative of, results of any other interim period or for the fiscal year taken as a whole. Certain information that is not required for interim financial reporting purposes has been omitted.

Inventory : As of June 30, 2024 and October 1, 2023, inventory included:

June 30, 2024 October 1, 2023
(Thousands)
June 30, 2024 October 1, 2023
Raw Material $ 9,302 $ 8,211
Work in Process 6,164 4,460
Finished Goods 659 489
Gross Inventory $ 16,125 $ 13,160
Less: Inventory Reserves ( 1,007 ) ( 1,007 )
Net Inventory $ 15,118 $ 12,153

F- 6

Concentration of Credit Risk : The Company’s accounts receivables as of June 30, 2024 consisted of U.S. government agencies ( 14 %), five major U.S. defense contractors ( 22 %, 11 %, 11 %, 10 %, and 6 %, respectively), one commercial customer ( 12 %) and all other customers ( 14 %). The Company does not believe that this concentration results in undue credit risk because of the financial strength of the customers and the Company’s long history with these customers.

Accrued Warranties : The Company accrues product warranty liabilities based on the historical return rate against period shipments as they occur and reviews and adjusts these accruals quarterly for any significant changes in estimated costs or return rates. The accrued warranty liability includes estimated costs to repair or replace returned warranty backlog units currently in-house plus estimated costs for future warranty returns that may be incurred against warranty covered products previously shipped as of the period end date. As of June 30, 2024 and October 1, 2023, the Company had warranty reserve balances of $ 36 thousand and $ 75 thousand, respectively.

June 30, 2024 July 2, 2023 June 30, 2024 July 2, 2023
Three months ended Nine months ended
June 30, 2024 July 2, 2023 June 30, 2024 July 2, 2023
Beginning balance $ 69 $ 266 $ 75 $ 169
Incurred costs for warranties satisfied during the period ( 15 ) ( 82 ) ( 52 ) ( 99 )
Warranty Expenses:
Warranties reserved for new product shipped during the period (1) 26 57 90 177
Change in estimate for pre-existing warranty liabilities (2) ( 44 ) - ( 77 ) ( 6 )
(Reversal of) Warranty Expense ( 18 ) 57 13 171
Ending balance $ 36 $ 241 $ 36 $ 241

(1) Warranty expenses accrued to cost of sales (based on current period shipments and historical warranty return rate.)
(2) Changes in estimated warranty liabilities recognized in cost of sales associated with: the period end customer returned warranty backlog, or the actual costs of repaired/replaced warranty units which were shipped to the customer during the current period.

Use of Estimates : The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.

Fair Value of Financial Instruments : Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of the financial statement presentation date.

The carrying value of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, are carried at, or approximate, fair value as of the reporting date because of their short-term nature. The credit facility is reported at fair value as it bears market rates of interest.

The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.

F- 7

The accounting guidance establishes a hierarchy which requires an entity to maximize the use of quoted market prices and minimize the use of unobservable inputs. An asset or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Fair value estimates are reviewed at the origination date and again at each applicable measurement date and interim or annual financial reporting dates, as applicable for the financial instrument, and are based upon certain market assumptions and pertinent information available to management at those times.

Revenue Recognition : The majority of the Company’s contracts and customer orders originate with fixed determinable unit prices for each deliverable quantity of goods defined by the customer order line item (performance obligation) and include the specific due date for the transfer of control and title of each of those deliverables to the customer at pre-established payment terms, which are generally within thirty to sixty days from the transfer of title and control. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods. In addition, the Company has one ongoing service contract which relates to optimized weapon system support (OWSS) and includes ongoing program maintenance, repairs and spare inventory support for the customer’s existing fleet units in service during the duration of the contract. Revenue recognition for this program has been recorded by the Company, and compensated by the customer, at fixed monthly increments over time, consistent with the defined contract maintenance period. During the three and nine months ended June 30, 2024, there was $ 126 thousand and $ 357 thousand in service contract revenue. During the three and nine months ended July 2, 2023, there was $ 115 thousand and $ 340 thousand in service contract revenue.

During the three- and nine-month periods ended June 30, 2024, there was $ 161 thousand of revenue recognized from customer deposit liabilities (deferred contract revenue). During the three- and nine-month periods ended July 2, 2023, there was zero and $ 223 thousand of revenue recognized from customer deposit liabilities (deferred contract revenue). As of June 30, 2024 and October 1, 2023, customer deposit liabilities were $ 320 thousand and $ 481 thousand, respectively.

As of June 30, 2024 and October 1, 2023, there was $ 250 and $ 336 thousand in accrued selling expenses and $ 237 and $ 336 thousand in contract assets related to a new $ 3.4 million contract booked in November 2022. The costs will be amortized against the revenue for the contract deliveries which began in the fourth quarter of fiscal year 2023 and extend into fiscal year 2025.

Contract Loss Reserves : The Company records loss provisions in the event that the current estimated total revenue against a contract and the total estimated cost remaining to fulfill the contract indicate a loss upon completion. When the estimated costs indicate a loss, we record the entire value of the loss against the contract loss reserve in the period the determination is made. The Company has several long-term fixed price contracts that are currently indicative of a loss condition due to recent inflationary pressures on material and labor, combined with increased manufacturing overhead costs. One of these long-term contracts has an option year ordering period ending in February 2025 with deliveries that may extend into February 2026. As of June 30, 2024 and October 1, 2023, the accrued contract loss reserves were $ 101 thousand and $ 243 thousand, respectively. During the three and nine months ended June 30, 2024, the Company recognized a gain on changes in estimates for the contract loss reserves of $ 16 thousand and $ 45 thousand and applied reserves of $ 34 thousand and $ 97 thousand to cost of sales against revenues booked during the periods, respectively.

Income Tax/Deferred Tax : As of June 30, 2024 and October 1, 2023, the Company had a deferred tax asset valuation allowance of ($ 0.8 ) million against deferred tax assets of $ 1.6 million and $ 1.7 million, respectively, for a net deferred tax asset of $ 0.8 million and $ 0.9 million, respectively. The valuation allowance has been established due to historical losses resulting in a Net Operating Loss Carryforward for each of the fiscal years 2011 through 2016 which may not be fully recognized due to an IRS Section 382 limitation related to a change in control. During the nine months ended June 30, 2024, our deferred tax assets decreased by $ 0.1 million related to temporary tax adjustments.

Earnings per Share : Basic earnings per share is computed by dividing income available for common shareholders (the numerator) by the weighted average number of common shares outstanding (the denominator) for the period. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

F- 8

The Company has potentially dilutive securities outstanding, which include unvested restricted stock units and unvested shares of restricted stock. The Company uses the Treasury Stock Method to compute the dilutive effect of any dilutive shares. Unvested restricted stock units and shares of restricted stock that are anti-dilutive are excluded from the calculation of diluted earnings per common share.

For the three and nine months ended June 30, 2024, 60,000 shares of unvested restricted stock and 66,500 unvested restricted stock units (which convert to an aggregate of 88,401 and 67,434 incremental shares), respectively, were included in the diluted earnings per share calculation. For the three and nine months ended July 2, 2023, 120,000 shares of unvested restricted stock (which convert to an aggregate of 43,141 and 35,011 incremental shares), respectively, were included in the diluted earnings per share calculation.

Note 3 - Segment Reporting

The Company’s two reportable segments, Applied Optics Center and Optex Richardson, are strategic businesses offering similar products to similar markets and customers; however, they are operated and managed separately due to differences in manufacturing technology, equipment, geographic location, and specific product mix. Applied Optics Center was acquired as a unit, and management at the time of the acquisition was retained.

The Applied Optics Center segment also serves as the key supplier of laser coated filters used in the production of periscope assemblies for the Optex Richardson segment. Intersegment sales and transfers are accounted for at annually agreed to pricing rates based on estimated segment product cost, which includes segment direct manufacturing and general and administrative costs, but exclude profits that would apply to third party external customers.

Optex Richardson – Richardson, Texas

Optex Richardson revenues are primarily in support of prime and subcontracted military customers. Military sales to prime and subcontracted customers represented approximately 98 % and sales to commercial customers represented approximately 2 % of the external segment revenue for the nine months ended June 30, 2024. The Optex Richardson segment revenue is comprised of approximately 85 % domestic military customers and 13 % foreign military customers. For the nine months ended June 30, 2024, Optex Richardson represented 50 % of the Company’s total consolidated revenue and consisted of revenue from the U.S. government ( 14 %), one major U.S. defense contractor ( 21 %) and all other customers ( 15 %).

Optex Richardson is located in Richardson Texas, with leased premises consisting of approximately 49,100 square feet. As of June 30, 2024, the Richardson facility operated with 77 full-time equivalent employees in a single shift operation which includes 8 home office support employees. The facilities at Optex Richardson serve as the home office for both the Optex Richardson and Applied Optics Center segments.

Applied Optics Center (AOC) – Dallas, Texas

The Applied Optics Center serves primarily domestic U.S. customers. Sales to commercial customers represented approximately 29 % and military sales to prime and subcontracted customers represented approximately 71 % of the external segment revenue for the nine months ended June 30, 2024. Approximately 95 % of the AOC revenue was derived from external customers and approximately 5 % was related to intersegment sales to Optex Richardson in support of military contracts. For the nine months ended June 30, 2024, AOC represented 50 % of the Company’s total consolidated revenue and consisted of revenue from the U.S government ( 5 %), two major defense contractor ( 8 % and 7 %), one commercial customer ( 14 %), and all other customers ( 16 %).

The Applied Optics Center is located in Dallas, Texas with leased premises consisting of approximately 44,867 square feet of space. As of June 30, 2024, AOC operated with 45 full-time equivalent employees in a single shift operation.

The financial tables below present information on the reportable segments’ profit or loss for each period, as well as segment assets as of each period end. The Company does not allocate interest expense, income taxes or unusual items to segments.

F- 9

Reportable Segment Financial Information

(thousands)

As of and for the three months ended June 30, 2024

Optex

Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and intersegment eliminations)

Consolidated

Total

Revenues from external customers $ 4,675 $ 4,385 $ - $ 9,060
Intersegment revenues - 282 ( 282 ) -
Total revenue $ 4,675 $ 4,667 $ ( 282 ) $ 9,060
Interest expense $ - $ - $ 17 $ 17
Depreciation and amortization $ 54 $ 78 $ - $ 132
Income (loss) before taxes $ 442 $ 1,263 $ ( 107 ) $ 1,598
Other significant noncash items:
Allocated home office expense $ ( 339 ) $ 339 $ - $ -
Stock compensation expense $ - $ - $ 90 $ 90
(Reversal of) Warranty expense $ - $ ( 18 ) $ - $ ( 18 )
Segment assets $ 16,449 $ 8,413 $ - $ 24,862
Expenditures for segment assets $ 159 $ 147 $ - $ 306

Reportable Segment Financial Information

(thousands)

As of and for the three months ended July 2, 2023

Optex Systems

Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and intersegment eliminations)

Consolidated

Total

Revenues from external customers $ 3,069 $ 4,103 $ - $ 7,172
Intersegment revenues - 265 ( 265 ) -
Total revenue $ 3,069 $ 4,368 $ ( 265 ) $ 7,172
Interest expense $ - $ - $ 22 $ 22
Depreciation and amortization $ 14 $ 72 $ - $ 86
Income (loss) before taxes $ ( 60 ) $ 893 $ ( 103 ) $ 730
Other significant noncash items:
Allocated home office expense $ ( 386 ) $ 386 $ - $ -
Stock compensation expense $ - $ - $ 81 $ 81
Warranty expense $ - $ 57 $ - $ 57
Segment assets $ 11,671 $ 9,293 $ - $ 20,964
Expenditures for segment assets $ - $ 222 $ - $ 222

F- 10

Reportable Segment Financial Information

(thousands)

As of and for the nine months ended June 30, 2024
Optex Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and intersegment eliminations)

Consolidated

Total

Revenues from external customers $ 12,344 $ 12,208 $ - $ 24,552
Intersegment revenues - 700 ( 700 ) -
Total revenue $ 12,344 $ 12,908 $ ( 700 ) $ 24,552
Interest expense $ - $ - $ 32 $ 32
Depreciation and amortization $ 103 $ 238 $ - $ 341
Income (loss) before taxes $ 850 $ 3,033 $ ( 392 ) $ 3,491
Other significant noncash items:
Allocated home office expense $ ( 1,019 ) $ 1,019 $ - $ -
Stock compensation expense $ - $ - $ 360 $ 360
Warranty expense $ 17 $ ( 4 ) $ - $ 13
Segment assets $ 16,449 $ 8,413 $ - $ 24,862
Expenditures for segment assets $ 1,331 $ 172 $ - $ 1,503

Reportable Segment Financial Information

(thousands)

As of and for the nine months ended July 2, 2023
Optex Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and intersegment eliminations)

Consolidated

Total

Revenues from external customers $ 7,742 $ 9,840 $ - $ 17,582
Intersegment revenues - 511 ( 511 ) -
Total revenue $ 7,742 $ 10,351 $ ( 511 ) $ 17,582
Interest expense $ - $ - $ 31 $ 31
Depreciation and amortization $ 38 $ 214 $ - $ 252
Income (loss) before taxes $ ( 527 ) $ 1,747 $ ( 165 ) $ 1,055
Other significant noncash items:
Allocated home office expense $ ( 978 ) $ 978 $ - $ -
Stock compensation expense $ - $ - $ 134 $ 134
Warranty expense $ - $ 171 $ - $ 171
Segment assets $ 11,671 $ 9,293 $ - $ 20,964
Expenditures for segment assets $ 25 $ 343 $ - $ 368

F- 11

Note 4 - Commitments and Contingencies

Non-cancellable Operating Leases

The Company leases its office and manufacturing facilities for the Optex Richardson location and the Applied Optics Center Dallas location. The Company also leases certain office equipment under non-cancellable operating leases.

The leased facility under Optex Systems located at 1420 Presidential Drive, Richardson, Texas consists of 49,100 square feet of space at the premises. The previous lease term for this location expired March 31, 2021 and the monthly base rent was $24.6 thousand through March 31, 2021. On January 11, 2021 the Company executed a sixth amendment extending the terms of the lease for eighty-six (86) months, commencing on April 1, 2021 and ending on May 31, 2028 . The initial base rent is set at $25.3 thousand and escalates 3% on April 1 each year thereafter. The initial term included 2 months of rent abatement for April and May of 2021. The monthly rent includes approximately $ 12 thousand for additional Common Area Maintenance fees and taxes (“CAM”), to be adjusted annually based on actual expenses incurred by the landlord.

The leased facility under the Applied Optics Center located at 9839 and 9827 Chartwell Drive, Dallas, Texas, consists of 44,867 square feet of space at the premises. The previous lease term for this location expired on October 31, 2021 and the monthly base rent was $21.9 thousand through the end of the lease. On January 11, 2021 the Company executed a first amendment extending the terms of the lease for eighty-six (86) months, commencing on November 1, 2021 and ending on December 31, 2028 . The initial base rent is set at $23.6 thousand as of January 1, 2022 and escalates 2.75% on January 1 each year thereafter. The initial term includes two months of rent abatement for November and December of 2021. The amendment provides for a five-year renewal option at the end of the lease term at the greater of the then “prevailing rental rate” or the then current base rental rate. Our obligations to make payments under the lease are secured by a $ 125,000 standby letter of credit. The monthly rent includes approximately $ 13 thousand for additional CAM, to be adjusted annually based on actual expenses incurred by the landlord.

The Company had one non-cancellable office equipment lease with a commencement date of October 1, 2018 and a term of 39 months. The lease cost for the equipment was $1.5 thousand per month from October 1, 2018 through December 31, 2021. The lease was renewed on November 18, 2021 for an additional 48 months at a cost of $1.2 thousand per month. The start of the lease was delayed until April 2022 due to temporary equipment shortages. The lease renewal resulted in the recognition of an additional right of use asset and a lease liability of $ 51 thousand during the year ended October 2, 2022.

F- 12

As of June 30, 2024, the remaining minimum base lease and estimated common area maintenance (CAM) payments under the non-cancellable office equipment and facility space leases are as follows:

Non-cancellable Operating Leases Minimum Payments

Fiscal Year Facility Lease Payments Facility Lease Payments Lease Payments Total Lease Payments Total Variable CAM Estimate
(Thousands)
Optex Richardson Applied Optics Center Office Equipment Consolidated
Fiscal Year Facility Lease Payments Facility Lease Payments Lease Payments Total Lease Payments Total Variable CAM Estimate
2024 Base year lease $ 83 $ 75 $ 4 $ 162 $ 75
2025 Base year lease 336 305 15 656 306
2026 Base year lease 346 313 3 662 312
2027 Base year lease 357 322 - 679 318
2028 Base year lease 242 330 - 572 249
2029 Base year lease - 83 - 83 43
Total base lease payments $ 1,364 $ 1,428 $ 22 $ 2,814 $ 1,303
Imputed interest on lease payments (1) ( 130 ) ( 155 ) ( 1 ) ( 286 )
Total Operating Lease Liability (2) $ 1,234 $ 1,273 $ 21 $ 2,528
Right-of-use Asset (3) $ 1,146 $ 1,195 $ 21 $ 2,362

(1) Assumes a discount borrowing rate of 5.0 % on the new lease amendments effective as of January 11, 2021 .
(2) Includes $ 166 thousand of unamortized deferred rent.
(3) Short-term and Long-term portion of Operating Lease Liability is $ 634 thousand and $ 1,894 thousand, respectively.

Total expense under both facility lease agreements for the three months ended June 30, 2024 and July 2, 2023 was $ 223 and $ 206 thousand, respectively. Total office equipment rentals included in operating expenses was $ 6 and $ 9 thousand for the three months ended June 30, 2024 and July 2, 2023, respectively.

Total expense under both facility lease agreements for the nine months ended June 30, 2024 and July 2, 2023 was $ 681 and $ 644 thousand, respectively. Total office equipment rentals included in operating expenses was $ 19 thousand and $ 18 thousand for the nine months ended June 30, 2024 and July 2, 2023, respectively.

F- 13

Note 5 - Debt Financing

Credit Facility — PNC Bank (formerly BBVA, USA)

On April 16, 2020, the Company and its subsidiary, Optex Systems, Inc. (collectively, the “Borrowers”), entered into a line of credit facility (the “PNC Facility”) with BBVA, USA. In June 2021, PNC Bank completed its acquisition of BBVA, USA and the bank name changed to PNC Bank (“PNC”). The substantive terms were as follows:

The principal amount of the PNC Facility was $ 2.25 million. The PNC Facility matured on April 15, 2022 . The interest rate was variable based on PNC’s Prime Rate plus a margin of 0.250 %, initially set at 3 % at loan origination, and all accrued and unpaid interest was payable monthly in arrears starting on May 15, 2020; and the principal amount was due in full with all accrued and unpaid interest and any other fees on April 15, 2022.
There were commercially standard covenants including, but not limited to, covenants regarding maintenance of corporate existence, not incurring other indebtedness except trade debt, not changing more than 25% stock ownership of Borrowers, and a Fixed Charge Coverage Ratio of 1.25:1, with the Fixed Charge Coverage Ratio defined as (earnings before taxes, amortization, depreciation, amortization and rent expense less cash taxes, distribution, dividends and fair value of warrants) divided by (current maturities on long term debt plus interest expense plus rent expense) .
The PNC Facility contained commercially standard events of default including, but not limited to, not making payments when due; incurring a judgment of $ 10,000 or more not covered by insurance; not maintaining collateral and the like.
The PNC Facility was secured by a first lien on all of the assets of Borrowers.

F- 14

On April 12, 2022, the Borrowers entered into an Amended and Restated Loan Agreement (the “PNC Loan Agreement”) with PNC, pursuant to which the PNC Facility was decreased from $ 2.25 million to $ 1.125 million, and t he maturity date was extended from April 15, 2022 to April 15, 2023 . The PNC Loan Agreement required the Borrowers to maintain a fixed charge coverage ratio of at least 1.25:1.

On November 21, 2022, the Borrowers issued an Amended and Restated Revolving Line of Credit Note (the “Line of Credit Note”) to PNC in connection with an increase of the Borrower’s revolving line of credit facility under the PNC Loan Agreement from $ 1.125 million to $ 2.0 million. The maturity date remained April 15, 2023 . Obligations outstanding under the credit facility accrued interest at a rate equal to the Lender’s prime rate minus 0.25 %.

The Line of Credit Note and PNC Loan Agreement contained customary events of default and negative covenants, including but not limited to those governing indebtedness, liens, fundamental changes, investments, and restricted payments. The PNC Facility was secured by substantially all of the operating assets of the Borrowers as collateral. The Borrowers’ obligations under the PNC Facility were subject to acceleration upon the occurrence of an event of default as defined in the Line of Credit Note and PNC Loan Agreement.

The PNC Facility was replaced by the Texas Capital Facility on March 22, 2023.

Credit Facility — Texas Capital Bank

On March 22, 2023, the Borrowers entered into a Business Loan Agreement (the “Loan Agreement”) with Texas Capital Bank (the “Lender”), pursuant to which the Lender will make available to the Borrowers a revolving line of credit in the principal amount of $ 3 million (the “Texas Capital Facility”). The Texas Capital Facility replaced the $ 2 million PNC Facility.

The commitment period for advances under the Texas Capital Facility is twenty-six months expiring on May 22, 2025 . We refer to the expiration of that time period as the “Maturity Date.” Outstanding advances under the Texas Capital Facility will accrue interest at a rate equal to the secured overnight financing rate (SOFR) plus a specified margin, subject to a specified floor interest rate. As of June 30, 2024 the interest rate was 8.07 % per annum.

The Loan Agreement contains customary events of default (including a 25 % change in ownership) and negative covenants, including but not limited to those governing indebtedness, liens, fundamental changes (including changes in management), investments, and restricted payments (including cash dividends). The Loan Agreement also requires the Borrowers to maintain a fixed charge coverage ratio of at least 1.25:1 and a total leverage ratio of 3.00:1 . The Texas Capital Facility is secured by substantially all of the operating assets of the Borrowers as collateral. The Borrowers’ obligations under the Texas Capital Facility are subject to acceleration upon the occurrence of an event of default as defined in the Loan Agreement. The Loan Agreement further provides for a $ 125,000 Letter of Credit sublimit. The Company was in compliance with all covenants as of June 30, 2024.

The outstanding balance under the Texas Capital Facility was $ 1.0 million as of June 30, 2024.

For the three months and nine months ended June 30, 2024, the total interest expense under the Texas Capital Facility was $ 17 thousand and $ 32 thousand, respectively.

F- 15

Note 6 - Stock Based Compensation

Restricted Stock, Performance Shares and Restricted Stock Units issued to Directors, Officers and Employees

The following table summarizes the status of Optex Systems Holdings’ aggregate non-vested restricted stock and restricted stock units and performance shares:

Restricted Stock Units Weighted Average Grant Date Fair Value Restricted Shares Weighted Average Grant Date Fair Value Performance Shares Weighted Average Grant Date Fair Value
Outstanding at October 2, 2022 66,000 $ 1.52 180,000 $ 1.75 - -
Granted 42,000 3.05 40,000 3.09 135,000 2.37
Vested ( 66,000 ) 1.52 ( 60,000 ) 1.75 - -
Forfeited ( 3,000 ) 3.00 ( 40,000 ) 1.75 - -
Outstanding at October 1, 2023 39,000 $ 3.06 120,000 $ 2.20 135,000 2.37
Granted 39,500 7.17 - - - -
Vested ( 12,000 ) 3.00 ( 60,000 ) 2.20 ( 135,000 ) 2.37
Forfeited - - - - - -
Outstanding at June 30, 2024 66,500 $ 5.51 60,000 $ 2.20 - $ -

On January 2, 2019, the Company granted 150,000 and 50,000 restricted stock units with a January 2, 2019 grant date to Danny Schoening and Karen Hawkins, respectively, vesting as of January 1 each year subsequent to the grant date over a three-year period at a rate of 34 % in year one, and 33 % each year thereafter. The stock price at grant date was $ 1.32 per share. Effective December 1, 2021, the vesting terms of Danny Schoening’s Restricted Stock Unit (RSU) grant from January 2019 were revised as described below. The Company amortizes the grant date fair value of $ 264 thousand to stock compensation expense on a straight-line basis across the three-year vesting period beginning on January 2, 2019. As of June 30, 2024, there was no unrecognized compensation cost relating to this award.

On February 17, 2020, the Company granted 50,000 restricted stock units to Bill Bates, General Manager of the Applied Optics Center. The restricted stock units vest as of January 1 each year subsequent to the grant date over a three-year period at a rate of 34 % in year one, and 33 % each year thereafter. The stock price at grant date was $ 2.13 per share. The Company amortized the grant date fair value of $ 107 thousand to stock compensation expense on a straight-line basis across the three-year vesting period beginning on February 17, 2020.

On April 30, 2020, the Board of Directors held a meeting and voted to increase the annual board compensation for the three independent directors from $ 22,000 to $ 36,000 with an effective date of January 1, 2020, in addition to granting 100,000 shares of restricted stock to each independent director which vest at a rate of 20% per year (20,000 shares) each January 1 st through January 1, 2025. The total fair value for the 300,000 shares was $ 525 thousand based on the stock price of $ 1.75 as of April 30, 2020. On each of January 1, 2021, January 1, 2022, and January 1, 2023, 60,000 of the restricted director shares vested. On February 16, 2023, 40,000 of the unvested restricted shares were forfeited and cancelled when one of the independent directors departed the Board.

The Company entered into an amended and restated employment agreement with Danny Schoening dated December 1, 2021. The updated employment agreement also served to amend Mr. Schoening’s RSU Agreement, dated January 2, 2019, by changing the third and final vesting date for the restricted stock units granted under such agreement from January 1, 2022 to the “change of control date,” that being the first of the following to occur with respect to the Company: (i) any “Person,” as that term is defined in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with certain exclusions, is or becomes the “Beneficial Owner” (as that term is defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities; or (ii) the Company is merged or consolidated with any other corporation or other entity, other than: (A) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (B) the Company engages in a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no “Person” (as defined above) acquires fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities. The amended RSU Agreement contains certain exceptions to the definition of change of control.

F- 16

As of the December 1, 2021 modification date related to the third and final vesting date of the 49,500 unvested restricted stock units held by Danny Schoening, there was no change in the fair value of the modified award as compared to the original award immediately prior to the modification date. The restricted stock units initially were certain to vest on January 1, 2022, but due to the modification, they were less certain to vest, contingent on a “change in control” occurring, which change in control, in case Mr. Schoening was terminated by the Company without cause or he resigns with good reason prior to such change in control, was required to occur prior to March 13, 2023. As of the modification date, there was $ 5 thousand of unrecognized compensation cost associated with the original award. As a matter of expediency, the unrecognized compensation expense as of the modification date was fully expensed through January 1, 2022. There is no additional compensation expense associated with the modification of the restricted stock unit agreement.

On November 28, 2022, the Company entered into a new employment agreement with Danny Schoening which amended Mr. Schoening’s RSU Agreement, dated January 2, 2019, which had been previously amended as of December 1, 2021, by changing the third and final vesting date for the restricted stock units granted under such agreement from the “change of control date” to January 1, 2023.

On January 4, 2023, the Company issued 46,432 common shares to Danny Schoening, CEO, and Bill Bates (AOC GM), net of tax withholding of $ 58 thousand, in settlement of 66,000 restricted stock units which vested on January 1, 2023.

On May 1, 2023, the Company granted an aggregate of 39,000 restricted stock units to eleven employees under its 2023 Equity Incentive Plan. As of the grant date, assuming a 23.1 % forfeiture rate based on expected turnover across the three years, the aggregate value of the restricted stock units is $ 90 thousand which will be amortized across the three-year period on a straight-line basis. During the twelve months ended October 1, 2023, there were 3,000 restricted stock units forfeited. On August 14, 2023 there was an additional grant of 3,000 restricted stock units to one new employee with a fair value of $ 11 thousand. The restricted stock units will vest at a rate of 33.33 % annually on the anniversary date of the grant and any unvested restricted stock units will be forfeited if employment terminates prior to the relevant vesting date.

As of June 30, 2024 and October 1, 2023, there were 66,500 and 39,000 unvested restricted stock units outstanding, respectively.

On May 3, 2023, the Board of Directors approved a grant of 100,000 and 35,000 performance shares to Danny Schoening, CEO, and Karen Hawkins, CFO, respectively. Each performance share represents a contingent right to receive one share of common stock. The performance shares vest in five equal increments if, in each case and during a five-year performance period beginning on October 2, 2023, the average VWAP per share of common stock over a 30 consecutive trading day period equals or exceeds $3.70, $4.45, $5.35, $6.40, or $7.70 . The fair value of the shares, as of the grant date, is $ 320 thousand and will be amortized through December 31, 2025 based on the derived service periods using a Monte Carlo simulation valuation model.

On May 9, 2023, the Board of Directors approved a grant of 40,000 shares of restricted stock to independent board member Dayton Judd. The shares vest 50 % on each of January 1, 2024 and January 1, 2025. As of the grant date, the fair value of the shares was $ 124 thousand, to be amortized on a straight-line basis through December 31, 2024. As of June 30, 2024, there were 60,000 unvested restricted shares outstanding.

On October 2, 2023, 27,000 performance shares vested for reaching the 30-day VWAP for Tranche 1. The Company issued a total of 21,060 shares on October 24, 2023 in settlement of the vested shares, net of tax withheld of $ 27 thousand.

On December 22, 2023 and December 29, 2023, 27,000 performance shares vested each date for reaching the 30-day VWAP for Tranche 2 and Tranche 3. On January 8, 2024 the Company issued a total of 39,563 shares in settlement of the vested shares, net of tax withheld of $ 91 thousand.

F- 17

On March 11, 2024, 27,000 performance shares vested each date for reaching the 30-day VWAP for Tranche 4. The Company issued a total of 20,669 shares on March 13, 2024 in settlement of the vested shares, net of tax withheld of $ 46 thousand.

On May 1, 2024, the Company granted an aggregate of 39,000 restricted stock units to eleven employees under its 2023 Equity Incentive Plan. As of the grant date, assuming a 7.7 % forfeiture rate based on expected turnover across the three years, the aggregate value of the restricted stock units is $ 258 thousand which will be amortized across the three-year period on a straight-line basis. The restricted stock units will vest at a rate of 33.33 % annually on the anniversary date of the grant and any unvested restricted stock units will be forfeited if employment terminates prior to the relevant vesting date. On June 4, 2024 there was an additional grant of 500 restricted stock units to one employee with a fair value of $ 4 thousand. The 500 restricted stock units will vest 100 % on the anniversary date of the grant and will be forfeited if employment terminates prior to the relevant vesting date.

On May 1, 2024, there were 12,000 shares vested under its 2023 Equity Incentive Plan for restricted stock units granted on May 1, 2023. On May 3, 2024, 8,446 shares were issued to ten employees, withheld of $ 26 thousand.

On May 17, 2024, 27,000 performance shares vested for reaching the 30-day VWAP for Tranche 5. The Company issued a total of 20,426 shares on May 17, 2024 in settlement of the vested shares, net of tax withheld of $ 53 thousand.

As of June 30, 2024, there were no performance shares remaining to vest.

The assumptions and results for the Monte Carlo simulation are as follows:

Schedule of Assumptions and Results for the Monte Carlo Simulation

Assumptions
Performance Period Start 10/2/2023
Performance Period End 10/1/2028
Term of simulation (1) 5.42 years
Time steps in simulation 1,365
Time steps per year 252
Common share price at valuation date (2) $ 3.04
Volatility (annual) (4) 50.0 %
Risk-free rate (annual) (5) 3.37 %
Cost of equity (6) 11.5 %
Dividend yield (3) 0.0 %

Tranche 1 Tranche 2 Tranche 3 Tranche 4 Tranche 5
Number of performance shares in the Tranche (1) 27,000 27,000 27,000 27,000 27,000
Fair Value of One Performance share (7) $ 2.75 $ 2.58 $ 2.39 $ 2.18 $ 1.93
Total Fair Value of Tranche $ 74,345 $ 69,742 $ 64,446 $ 58,819 $ 52,238
Derived Service Period (Years) (7) 0.71 1.13 1.60 2.06 2.48

(1) Based on the terms of the Performance Shares agreement issued by the Company on May 3, 2023.

(2) Closing price of OPXS shares on the Valuation Date, as obtained via S&P Capital IQ.

(3) Expected dividends provided by management.

(4) Based on historical volatility of OPXS and comparable public companies.

(5) Interest rate for US Treasury commensurate with the Performance Shares holding period, as of the Valuation Date, as obtained via S&P Capital IQ.

(6) Estimated cost of equity for OPXS as of the Valuation Date.

(7) Based on Monte Carlo simulation.

F- 18

Stock Based Compensation Expense

Equity compensation is amortized based on a straight-line basis across the vesting or service period as applicable. The recorded compensation costs for restricted shares granted and restricted stock units and performance shares awarded as well as the unrecognized compensation costs are summarized in the table below:

Schedule of Unrecognized Compensation Costs

Stock Compensation
(thousands)

Recognized Compensation

Expense

Unrecognized Compensation

Expense

Three months ended Nine months ended As of period ended

June 30,

2024

July 2,
2023

June 30,

2024

July 2,
2023
June 30,
2024
October 1,
2023
Restricted Shares $ 33 $ 33 $ 107 $ 78 $ 66 $ 173
Performance Shares 33 43 212 43 - 212
Restricted Stock Units 24 5 41 13 309 77
Total Stock Compensation $ 90 $ 81 $ 360 $ 134 $ 375 $ 462

Note 7 – Asset Purchase of Intellectual Property

On January 18, 2024, Optex Systems Holdings, Inc., through its wholly-owned subsidiary Optex Systems, Inc. (collectively, the “Company”), entered into an asset purchase agreement and a contract manufacturing agreement with RUB Aluminum s.r.o. (“RUB”). Under the agreements, the Company acquired certain intellectual property and technical and marketing information relating to the Speedtracker Mach product line, which is primarily used for firearm projectile speed detection, measuring and tracking. RUB may continue to manufacture Speedtracker Mach products on behalf of the Company. The Company acquired the assets using $ 1 million in cash on hand, with potential additional future cash payments based on successful completion of defined milestones. The initial term of the contract manufacturing agreement is one year, subject to additional one-year renewal terms to which both parties must agree. Subsequent to the acquisition, the Company has determined it would be more economical to move the manufacturing operations in house and is no longer ordering assembled units against the contract manufacturing agreement.

The acquisition included transaction costs of $30 thousand for legal fees. Pursuant to the asset purchase agreement, the total earnout payment would have been $238 thousand only if the earnout revenue milestones were achieved during the earnout period, otherwise the earnout would be zero . As of January 18, 2024, the fair value of the contingent liability was $ 83 thousand. As of June 30, 2024, it was determined that the revenue milestones related to the earnout agreement would be unachievable within the earnout period and the fair value of the contingent liability related to the earnout was set to zero.

The intangible asset will be amortized on a straight-line basis over seven years and reviewed annually at each fiscal year end for possible impairment.

As of June 30, 2024 the value of intangible assets is:

June 30, 2024
Intangible Assets – Intellectual Property $ 1,030
Amortization of Intangible Assets ( 61 )
Net Intangible Assets $ 969

F- 19

Note 8 - Stockholders’ Equity

Dividends

No dividends were declared or paid during the three and nine months ended June 30, 2024 or the twelve months ended October 1, 2023.

Common Stock

On September 22, 2021, the Company announced authorization of a $ 1 million stock repurchase program. The shares authorized to be repurchased under the repurchase program may be purchased from time to time at prevailing market prices, through open market transactions or in negotiated transactions, depending upon market conditions and subject to Rule 10b-18 as promulgated by the SEC.

During the three and nine months ended July 2, 2023 and June 30, 2024, there were zero common shares repurchased under the program.

During the three and nine months ended June 30, 2024, the Company issued 20,426 and 101,718 shares to Danny Schoening and Karen Hawkins in settlement of 27,000 and 135,000 performance shares, which vested during the three and nine months, respectively. The shares were issued net of 6,574 and 33,282 shares withheld for taxes.

During the three and nine months ended June 30, 2024, the Company issued 8,446 shares to ten employees in settlement of 12,000 restricted stock units, which vested during the three and nine months. The shares were issued net of 3,554 shares withheld for taxes.

As of June 30, 2024 and October 1, 2023, total outstanding common shares were 6,873,234 and 6,763,070 , respectively.

Note 9 - Subsequent Events

There are none.

F- 20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to supplement and complement our audited consolidated financial statements and notes thereto for the fiscal year ended October 1, 2023 and our unaudited condensed consolidated financial statements and notes thereto for the quarter ended June 30, 2024, prepared in accordance with U.S. generally accepted accounting principles (GAAP). You are encouraged to review our consolidated financial statements in conjunction with your review of this MD&A. The financial information in this MD&A has been prepared in accordance with GAAP, unless otherwise indicated. In addition, we use non-GAAP financial measures as supplemental indicators of our operating performance and financial position. We use these non-GAAP financial measures internally for comparing actual results from one period to another, as well as for planning purposes. We will also report non-GAAP financial measures as supplemental information, as we believe their use provides more insight into our performance. When a non-GAAP measure is used in this MD&A, it is clearly identified as a non-GAAP measure and reconciled to the most closely corresponding GAAP measure.

The following discussion highlights the principal factors that have affected our financial condition and results of operations as well as our liquidity and capital resources for the periods described. The operating results for the periods presented were not significantly affected by inflation.

Cautionary Note Regarding Forward-Looking Information

This Quarterly Report on Form 10-Q, in particular the MD&A, contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements contained in this Quarterly Report on Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. When used in this Quarterly Report on Form 10-Q and other reports, statements, and information we have filed with the Securities and Exchange Commission (“Commission” or “SEC”), in our press releases, presentations to securities analysts or investors, or in oral statements made by or with the approval of an executive officer, the words or phrases “believes,” “may,” “will,” “expects,” “should,” “continue,” “anticipates,” “intends,” “will likely result,” “estimates,” “projects” or similar expressions and variations thereof are intended to identify such forward-looking statements.

These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding growth strategy; product and development programs; financial performance and financial condition (including revenue, net income, profit margins and working capital); orders and backlog; expected timing of contract deliveries to customers and corresponding revenue recognition; increases in the cost of materials and labor; costs remaining to fulfill contracts; contract loss reserves; labor shortages; follow-on orders; supply chain challenges; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations; and the economy in general or the future of the defense industry.

We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. Such risks and uncertainties include, but are not limited to, continued funding of defense programs and military spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company’s markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in the U.S. Government’s interpretation of federal procurement rules and regulations, changes in spending due to policy changes in any new federal presidential administration, market acceptance of the Company’s products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, increases in tax rates, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, unanticipated costs under fixed-price service and system integration engagements, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control. Some of these risks and uncertainties are identified in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and the section “Risk Factors” in our Annual Report on Form 10-K and you are urged to review those sections. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.

1

We do not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K.

Background

Optex Systems Holdings, Inc. (together with its subsidiaries, the “Company,” “we,” “us” and “our) manufactures optical sighting systems and assemblies, primarily for Department of Defense applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and armored security vehicles and have been selected for installation on the Stryker family of vehicles. We also manufacture and deliver numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Our products consist primarily of build-to-customer print products that are delivered both directly to the armed services and to other defense prime contractors. Less than 1% of today’s revenue is related to the resale of products substantially manufactured by others. In this case, the product would likely be a simple replacement part of a larger system previously produced by us.

We are both a prime and sub-prime contractor to the Department of Defense. Sub-prime contracts are typically issued through major defense contractors such as General Dynamics Land Systems, Raytheon Corp., BAE Systems plc, ADS Inc. and others. We are also a military supplier to foreign governments such as Israel, Australia and South American countries and as a subcontractor for several large U.S. defense companies serving foreign governments.

The Federal Acquisition Regulation is the principal set of regulations that govern the acquisition process of government agencies and contracts with the U.S. government. In general, parts of the Federal Acquisition Regulation are incorporated into government solicitations and contracts by reference as terms and conditions effecting contract awards and pricing solicitations .

Many of our contracts are prime or subcontracted directly with the Federal government and, as such, are subject to Federal Acquisition Regulation Subpart 49.5, “Contract Termination Clauses” and more specifically Federal Acquisition Regulation clauses 52.249-2 “Termination for Convenience of the Government (Fixed-Price)”, and 49.504 “Termination of fixed-price contracts for default”. These clauses are standard clauses on our prime military contracts and generally apply to us as subcontractors. It has been our experience that the termination for convenience is rarely invoked, except where it is mutually beneficial for both parties. We are currently not aware of any pending terminations for convenience or for default on our existing contracts.

In the event a termination for convenience were to occur, Federal Acquisition Regulation clause 52.249-2 provides for full recovery of all contractual costs and profits reasonably occurred up to and as a result of the terminated contract. In the event a termination for default were to occur, we could be liable for any excess cost incurred by the government to acquire supplies from another supplier similar to those terminated from us. We would not be liable for any excess costs if the failure to perform the contract arises from causes beyond the control and without the fault or negligence of the Company as defined by Federal Acquisition Regulation clause 52.249-8.

In addition, some of our contracts allow for government contract financing in the form of contract progress payments pursuant to Federal Acquisition Regulation 52.232-16, “Progress Payments”. As a small business, and subject to certain limitations, this clause provides for government payment of up to 90% of incurred program costs prior to product delivery. To the extent our contracts allow for progress payments, we intend to utilize this benefit, thereby minimizing the working capital impact on us for materials and labor required to complete the contracts.

2

Recent Events

January 2024 Asset Acquisition

On January 18, 2024, we entered into an asset purchase agreement and a contract manufacturing agreement with RUB Aluminium s.r.o. (“RUB”). Under the agreements, the Company acquired certain intellectual property and technical and marketing information relating to the Speedtracker Mach product line, which is primarily used for firearm projectile speed detection, measuring and tracking. RUB will continue to manufacture Speedtracker Mach products on behalf of the Company. The Company acquired the assets using $1 million in cash on hand, with potential additional future cash payments based on successful completion of defined milestones. The initial term of the contract manufacturing agreement is one year, subject to additional one-year renewal terms to which both parties must agree. Subsequent to the acquisition, the Company has determined it would be more economical to move the manufacturing operations in house and is no longer ordering assembled units against the contract manufacturing agreement.

The acquisition included transaction costs of $30 thousand for legal fees and a contingent liability for payment against an earnout agreement based on meeting certain revenue milestones. As of June 30, 2024, the fair value of the contingent liability was zero. Pursuant to the asset purchase agreement, the total earnout payment will be $238 thousand only if the earnout revenue milestone is achieved during the earnout period, otherwise the earnout will be zero. As of June 30, 2024 the Company determined the likelihood of achieving the revenue milestone during the earnout period was highly unlikely. The asset will be amortized on a straight-line basis over a seven-year period.

Material Trends

Recent supply chain disruptions have strained our suppliers and extended supplier delivery lead times, affecting our ability to sustain operations. We anticipate market wide material shortages for paint and resin products as well as critical epoxies and chemicals used in our manufacturing process. In addition, we have seen substantial increases in the costs of aluminum, steel and acrylic commodities, which has affected our net income in the year ended October 1, 2023 and the three and nine months ended June 30, 2024, and is expected to continue to have a negative effect on the margins expected to be generated under our long-term fixed contracts over the next two years. See also “ Item 1A. Risk Factors – Risks Related to Our Business - Certain of our products are dependent on specialized sources of supply potentially subject to disruption which could have a material, adverse impact on our business” in our Annual Report on Form 10-K for the year ended October 1, 2023.

We have also experienced significant material shortages during the year ended October 1, 2023 and extending into the first nine months of fiscal year 2024 from several significant suppliers of our periscope covers and housings. These shortages affect several of our periscope products at the Optex Richardson segment. The delays in key components, combined with labor shortages during the year ended October 1, 2023 and continuing into the first nine months of fiscal year 2024, have negatively impacted our production levels and continue to push back expected delivery dates. We are actively seeking alternative sources as well as expediting our current suppliers for these components. We are also increasing employee recruitment initiatives and overtime to attempt to mitigate any continuing risks to the periscope line.

We are seeing some recent improvements in the local labor market and are adding to our direct labor force in concert with improvements in our supplier delivery performance. While we are encouraged by improvements in supplier performance for the Optex Richardson segment periscope line which yielded increased revenue performance during fiscal year 2023 and into the first nine months of fiscal 2024, we have yet to ramp up deliveries sufficiently to keep pace with our current customer demands. As such, we cannot give any assurances that expected customer delivery dates for our periscope products will not experience further delays.

In March 2023, we moved our line of credit from PNC Bank to Texas Capital Bank and increased our available line of credit to $3.0 million from the previous $2.0 million line with PNC. The increase in credit limit helps us meet our working capital requirements in light of the increased backlog and delay of revenues from the fiscal year 2023.

We refer also to “ Item 1. Business – Market Opportunity: U.S. Military in our Annual Report on Form 10-K for the year ended October 1, 2023 for a description of current trends in U.S. government military spending and its potential impact on Optex, which may be material, including particularly the tables included in that section and disclosure on the significant reduction in spending for U.S. ground system military programs, which has a direct impact on the Optex Richardson segment revenue, all of which is incorporated herein by reference.

3

Results of Operations

Non-GAAP Ad j usted EBITDA

We use adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) as an additional measure for evaluating the performance of our business as “net income” includes the significant impact of noncash compensation expenses related to equity stock grants, as well as depreciation, amortization, interest expenses and federal income taxes. We believe that Adjusted EBITDA is a meaningful indicator of our operating performance because it permits period-over-period comparisons of our ongoing core operations before the excluded items, which we do not consider relevant to our operations. Adjusted EBITDA is a financial measure not required by, or presented in accordance with, U.S. generally accepted accounting principles (“GAAP”).

Adjusted EBITDA has limitations and should not be considered in isolation or a substitute for performance measures calculated under GAAP. This non-GAAP measure excludes certain cash expenses that we are obligated to make. In addition, other companies in our industry may calculate Adjusted EBITDA differently than we do or may not calculate it at all, which limits the usefulness of Adjusted EBITDA as a comparative measure.

The table below summarizes our three-and nine-month operating results for the periods ended June 30, 2024 and July 2, 2023, in terms of both the GAAP net income measure and the non-GAAP Adjusted EBITDA measure. We believe that including both measures allows the reader better to evaluate our overall performance.

(Thousands)
Three months ended Nine months ended
June 30, 2024 July 2, 2023 June 30, 2024 July 2, 2023
Net Income (GAAP) $ 1,261 $ 576 $ 2,754 $ 832
Add:
Federal Income Tax Expense 337 154 737 223
Depreciation 132 86 341 252
Stock Compensation 90 81 360 134
Interest Expense 17 22 32 31
Adjusted EBITDA - Non GAAP $ 1,837 $ 919 $ 4,224 $ 1,472

Our net income increased by $0.7 million to $1.3 million for the three months ended June 30, 2024, as compared to net income of $0.6 million for the prior year period. Our adjusted EBITDA increased by $0.9 million to $1.8 million for the three months ended June 30, 2024, as compared to $0.9 million for the prior year period.

Our net income increased by $1.9 million to $2.8 million for the nine months ended June 30, 2024, as compared to a net income of $0.8 million for the prior year period. Our adjusted EBITDA increased by $2.7 million to $4.2 million for the nine months ended June 30, 2024, as compared to $1.5 million for the prior year period.

The increase in the most recent three and nine-month period net income and adjusted EBITDA is primarily driven by increased revenue and gross profit, which was only partially offset by increased general and administrative expenses. Operating segment performance is discussed in greater detail throughout the following sections.

4

Results of Operations Selective Financial Information

(Thousands)

Three months ended
June 30, 2024 July 2, 2023

Optex

Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and eliminations)

Consolidated

Optex

Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and eliminations)

Consolidated
Revenue from External Customers $ 4,675 4,385 - 9,060 $ 3,069 $ 4,103 $ - $ 7,172
Intersegment Revenues - 282 (282 ) - - 265 (265 ) -
Total Segment Revenue 4,675 4,667 (282 ) 9,060 3,069 4,368 (265 ) 7,172
Total Cost of Sales 3,575 2,886 (282 ) 6,179 2,757 2,968 (265 ) 5,460
Gross Profit 1,100 1,781 - 2,881 312 1,400 - 1,712
Gross Margin % 23.5 % 38.2 % - 31.8 % 10.2 % 32.1 % - 23.9 %
General and Administrative Expense 997 179 90 1,266 758 121 81 960
Segment Allocated G&A Expense (339 ) 339 - - (386 ) 386 - -
Net General & Administrative Expense 658 518 90 1,266 372 507 81 960
Operating Income (Loss) 442 1,263

(90

) 1,615 (60 ) 893 (81 ) 752
Operating Income (Loss) % 9.5 % 27.1 % - 17.8 % (2.0 )% 20.4 % - 10.5 %
Interest Expense - - 17 17 - - 22 22
Net Income (Loss) before taxes $ 442 1,263 (107 ) 1,598 $ (60 ) $ 893 $ (103 ) $ 730
Net Income (Loss) % 9.5 % 27.1 % - 17.6 % (2.0 )% 20.4 % - 10.2 %

5

Results of Operations Selected Financial Info by Segment

(Thousands)

Nine months ended
June 30, 2024 July 2, 2023

Optex

Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and eliminations)

Consolidated

Optex

Richardson

Applied Optics Center

Dallas

Other

(non-allocated costs and eliminations)

Consolidated
Revenue from External Customers $ 12,344 12,208 - 24,552 $ 7,742 $ 9,840 $ - $ 17,582
Intersegment Revenues - 700 (700 ) - - 511 (511 ) -
Total Segment Revenue 12,344 12,908 (700 ) 24,552 7,742 10,351 (511 ) 17,582
Total Cost of Sales 9,763 8,367 (700 ) 17,430 6,830 7,280 (511 ) 13,599
Gross Profit 2,581 4,541 - 7,122 912 3,071 - 3,983
Gross Margin % 20.9 % 35.2 % - 29.0 % 11.8 % 29.7 % - 22.7 %
General and Administrative Expense 2,750 489 360 3,599 2,417 346 134 2,897
Segment Allocated G&A Expense (1,019 ) 1,019 - - (978 ) 978 - -
Net General & Administrative Expense 1,731 1,508 360 3,599 1,439 1,324 134 2,897
Operating Income (Loss) 850 3,033 (360 ) 3,523 (527 ) 1,747 (134 ) 1,086
Operating Income (Loss) % 6.9 % 23.5 % - 14.3 % (6.8 )% 16.9 % - 6.2 %
Interest Expense - - 32 32 - - 31 31
Income (Loss) before taxes $ 850 3,033 (392 ) 3,491 $ (527 ) $ 1,747 $ (165 ) $ 1,055
Income (loss) before taxes % 6.9 % 23.5 % - 14.2 % (6.8 )% 16.9 % - 6.0 %

For the three months ended June 30, 2024, our total revenues increased by $1.9 million, or 26.3%, compared to the prior year period. For the nine months ended June 30, 2024, our total revenues increased by $7.0 million, or 39.6%, compared to the prior year period. The increase in revenue for the three and nine-month periods was driven by increased customer demand for military products across both operating segments partially offset by lower customer demand in commercial optical assemblies.

Consolidated gross profit for the three months ended June 30, 2024 increased by $1.2 million, or 68.3%, compared to the prior year period. Consolidated gross profit for the nine months ended June 30, 2024 increased by $3.1 million, or 78.8%, compared to the prior year period. The increase in the most recent three and nine-month period’s gross margin was primarily attributable to higher revenue spread across a fixed manufacturing cost base combined with changes in product mix and improved pricing and operating performance in both operating segments.

Our operating income for the three months ended June 30, 2024 increased by $0.9 million, or 114.8%, compared to the prior year period. Our operating income for the nine months ended June 30, 2024 increased by $2.4 million, or 224.4%, compared to the prior year period. The increase in operating income for the three and nine-month periods was primarily driven by higher revenue and increased gross margin in both operating segments.

6

New Orders and Backlog

Product backlog represents the value of unfulfilled customer manufacturing orders yet to be recognized as revenue. While backlog is not a non-GAAP financial measure, it is also not defined by GAAP. Therefore, our methodology for calculating backlog may not be consistent with methodologies used by other companies. The booked backlog by period may also not be fully indicative of the predicted revenues for those periods as many of our orders provide for accelerated delivery without penalty and may additionally provide customers the option to adjust schedules to meet their most recent projected demand quantities. However, we provide customer order and backlog information as we believe it provides significant insight into forward demand, with some predictive power to short term future revenues.

During the nine months ended June 30, 2024, the Company booked $28.3 million in new orders, representing a 7.6% increase over the prior year period. The orders for the most recently completed nine months consist of $18.5 million for our Optex Richardson segment and $9.8 million attributable to the Applied Optics Center segment.

The following table depicts the new customer orders for the nine months ending June 30, 2024 as compared to the prior year period in millions of dollars:

(Millions)
Product Line Nine months ended
June 30, 2024
Nine months ended
July 2, 2023
Variance % Chg
Periscopes $ 15.9 $ 11.6 $ 4.3 37.1 %
Sighting Systems 0.3 4.0 (3.7 ) (92.5 )%
Howitzer - - - - %
Other 2.3 3.0 (0.7 ) (23.3 )%
Optex Systems – Richardson 18.5 18.6 (0.1 ) (0.5 )%
Optical Assemblies 1.8 1.2 0.6 50.0 %
Laser Filters 6.5 5.5 1.0 18.2 %
Day Windows 0.1 0.1 - - %
Other 1.4 0.9 0.5 55.6 %
Applied Optics Center – Dallas 9.8 7.7 2.1 27.3 %
Total Customer Orders $ 28.3 $ 26.3 $ 2.0 7.6 %

During the current year nine-month period ended June 30, 2024, orders in the Company’s Optex Richardson segment decreased by ($0.1) million, or (0.5%) as compared to the prior year period. The primary reason for the decrease relates to a prior year award for $3.4 million in sighting systems to repair and refurbish night vision equipment for the Government of Israel. We began shipments against the contract in December 2023. The decrease in orders for sighting systems and other products was offset by a significant increase in periscope orders in the current year nine-month period. The Applied Optics Center orders increased $2.1 million, or 27.3% as we continue to see increases in orders for laser filter units for several prime government contractors, in addition to an increase in customer orders for commercial optical assemblies and other products driven by our new program of Infrared (IR) Signature Reduction Coatings used on aircraft.

7

Backlog as of June 30, 2024 was $45.6 million. This compares to a backlog of $41.8 million as of October 1, 2023, representing an increase of $3.8 million, or 9.1%, and a backlog of $41.6 million as of July 2, 2023, representing an increase of $4.0 million, or 9.6%. The following table depicts the current expected delivery by period of all contracts awarded as of June 30, 2024 in millions of dollars:

Product Line Q4-2024
Delivery
2025+
Delivery
Total Backlog
6/30/24
Total Backlog
7/2/23
Variance % Chg
Periscopes $ 3.7 $ 19.3 $ 23.0 $ 13.1 $ 9.9 75.6 %
Sighting Systems 0.5 3.5 4.0 5.2 (1.2 ) (23.1 )%
Howitzer - 2.3 2.3 2.3 - - %
Other 0.8 2.6 3.4 5.5 (2.1 ) (38.2 )%
Optex Richardson 5.0 27.7 32.7 26.1 6.6 25.3 %
Optical Assemblies 0.6 0.7 1.3 3.3 (2.0 ) (60.6 )%
Laser Filters 2.4 6.8 9.2 9.8 (0.6 ) (6.1 )%
Day Windows 0.2 1.1 1.3 1.8 (0.5 ) (27.8 )%
Other 0.3 0.8 1.1 0.6 0.5 83.3 %
Applied Optics Center - Dallas 3.5 9.4 12.9 15.5 (2.6 ) (16.8 )%
Total Backlog $ 8.5 $ 37.1 $ 45.6 $ 41.6 $ 4.0 9.6 %

Optex Richardson backlog as of June 30, 2024, was $32.7 million as compared to a backlog of $26.1 million as of July 2, 2023, representing an increase of $6.6 million or 25.3%.

Applied Optics Center backlog as of June 30, 2024, was $12.9 million as compared to a backlog of $15.5 million as of July 2, 2023, representing a decrease of ($2.6) million or (16.8%). Subsequent to the end of the quarter, on July 8, 2024, the Company announced a $2.5 million order for laser filter units to be delivered from August 2024 through July 2025.

Please refer to “ Material Trends ” above and “ Liquidity and Capital Resources ” below for more information on recent developments and trends with respect to our orders and backlog, which information is incorporated herein by reference.

The Company continues to pursue domestic, international and commercial opportunities in addition to maintaining its current footprint with U.S. vehicle manufactures, with existing as well as new product lines. We are also reviewing potential products outside our traditional product lines, which could be manufactured using our current production facilities in order to capitalize on our existing excess capacity.

Three Months Ended June 30, 2024 Compared to the Three Months Ended July 2, 2023

Revenue . For the three months ended June 30 2024, revenue increased by $1.9 million or 26.3% compared to the prior year period as set forth in the table below:

Three months ended
(Thousands)
Product Line June 30, 2024 July 2, 2023 Variance % Chg
Periscopes $ 3,171 $ 2,623 $ 548 20.9 %
Sighting Systems 432 137 295 215.3 %
Howitzers - - - -
Other 1,072 309 763 246.9 %
Optex Richardson 4,675 3,069 1,606 52.3 %
Optical Assemblies 963 1,452 (489 ) (33.7 )%
Laser Filters 2,941 2,286 655 28.7 %
Day Windows 109 120 (11 ) (9.2 )%
Other 372 245 127 51.8 %
Applied Optics Center - Dallas 4,385 4,103 282 6.9 %
Total Revenue $ 9,060 $ 7,172 $ 1,888 26.3 %

8

Optex Richardson revenue increased by $1.6 million or 52.3% for the three months ended June 30, 2024 as compared to the prior year period on higher customer demand for periscopes, sighting systems and other products including collimators, cell assemblies, and spare parts.

Applied Optics Center revenue increased by $0.3 million or 6.9% for the three months ended June 30, 2024 as compared to the prior year period. The revenue increase is primarily attributable to increased customer demand for laser filters and other products driven by our new program of Infrared (IR) Signature Reduction Coatings used on aircraft partially offset by lower customer demand for commercial optical assemblies.

Gross Margin . The gross margin during the three-month period ended June 30, 2024 was 31.8% of revenue as compared to a gross margin of 23.9% of revenue for the prior year period. The increase in gross profit is primarily attributable to higher revenue, changes in product mix, and increased absorption of fixed overhead across a higher revenue mix. Cost of sales increased to $6.2 million for the current period as compared to the prior year period of $5.5 million on higher revenue.

G&A Expenses . During the three months ended June 30, 2024 and July 2, 2023, we recorded operating expenses of $1.3 million and $1.0 million, respectively. Operating expenses increased by 31.9% between the respective periods primarily due to increased spending on royalties, selling expenses, investor relations, IT support services and legal expenses.

Operating Income . During the three months ended June 30, 2024, we recorded operating income of $1.6 million, as compared to operating income of $0.8 million during the three months ended July 2, 2023. The $0.8 million increase in operating income for the current year period from the prior year period is primarily due to increased revenue and gross margin, partially offset by higher general and administrative spending.

Nine months Ended June 30, 2024 Compared to the Nine months Ended July 2, 2023

Revenue . For the nine months ended June 30, 2024, revenues increased by $7.0 million or 39.6% compared to the prior year period as set forth in the table below:

Nine months ended
(Thousands)
Product Line June 30, 2024 July 2, 2023 Variance % Chg
Periscopes $ 7,842 $ 6,085 $ 1,757 28.9 %
Sighting Systems 1,003 464 539 116.2 %
Howitzers - - - -
Other 3,499 1,193 2,306 193.3 %
Optex Systems - Richardson 12,344 7,742 4,602 59.4 %
Optical Assemblies 3,252 4,438 (1,186 ) (26.7 )%
Laser Filters 7,208 4,404 2,804 63.7 %
Day Windows 460 350 110 31.4 %
Other 1,288 648 640 98.8 %
Applied Optics Center - Dallas 12,208 9,840 2,368 24.1 %
Total Revenue $ 24,552 $ 17,582 $ 6,970 39.6 %

Optex Richardson revenue increased by $4.6 million or 59.4% for the nine months ended June 30, 2024 as compared to the prior year period on higher customer demand for periscopes, sighting systems and other products including collimators, cell assemblies, and spare parts.

Applied Optics Center revenue increased by $2.4 million or 24.1% for the nine months ended June 30, 2024 as compared to the prior year period. The revenue increase is primarily attributable to increased customer demand for laser filters and other products driven by our new program of Infrared (IR) Signature Reduction Coatings used on aircraft partially offset by lower customer demand for commercial optical assemblies.

9

Gross Margin . The gross margin during the nine-month period ended June 30, 2024 was 29.0% as compared to a gross margin of 22.7% for the prior year period. The increase in gross profit is primarily attributable to higher revenue, changes in product mix, and increased absorption of fixed overhead across a higher revenue mix. Cost of sales increased to $17.4 million for the nine months ended June 30, 2024 as compared to the prior year period of $13.6 million on higher revenue.

G&A Expenses . During the nine months ended June 30, 2024 and July 2, 2023, we recorded operating expenses of $3.6 million and $2.9 million, respectively. Operating expenses increased by 24.2% between the respective periods primarily due to increased spending on labor, stock compensation, royalties, selling expenses, investor relations and IT support services.

Operating Income . During the nine months ended June 30, 2024, we recorded operating income of $3.5 million, as compared to an operating income of $1.1 million during the nine months ended July 2, 2023. The $2.4 million increase in operating income is primarily due to increased revenue and gross margin, partially offset by higher general and administrative spending.

Liquidity and Capital Resources

As of June 30, 2024, the Company had working capital of $14.2 million, as compared to $13.5 million as of October 1, 2023.

During the nine months ended June 30, 2024, we generated operating cash of $1.0 million, and spent $1.5 million on acquisitions of equipment and intangible assets. During the period, our inventory increased $3.0 million in support of new program awards, higher backlog and increasing revenues anticipated over the next twelve months.

The Company has capital commitments of $0.4 million for the purchase of property and equipment consisting of a significant coating chamber upgrade, an Opotek tunable laser system and a laser engraving machine.

Backlog as of June 30, 2024 was $45.6 million as compared to backlog of $41.6 million as of July 2, 2023 and $41.8 million as of October 1, 2023, representing an increase of 9.6% and 9.1%, respectively. For further details, see “ Results of Operations – New Orders and Backlog ” above.

The Company has historically funded its operations through cash from operations, convertible notes, common and preferred stock offerings and bank debt. The Company’s ability to generate positive cash flows depends on a variety of factors, including the continued development and successful marketing of the Company’s products.

At June 30, 2024, the Company had $0.5 million in cash and an outstanding payable balance of $1.0 million against its line of credit. At June 30, 2024, our outstanding accounts receivable balance was $3.3 million. We expect the accounts to be collected during the fourth quarter of fiscal 2024.

We refer to the disclosure under “Material Trends” with respect to recent supply chain disruptions and material shortages, which disclosure is incorporated herein by reference.

In the short term, the Company plans to utilize its current cash, available line of credit and operating cash flow to fund inventory purchases in support of the backlog growth and higher anticipated revenue during the next twelve months. Short term cash in excess of our working capital needs may be also be used to fund the purchase of product lines and other assets, including property and equipment required to maintain or meet our growing backlog, in addition to repurchasing common stock against our current stock repurchase plan. Longer term, excess cash beyond our operating needs may be used to fund new product development, company or product line acquisitions, or additional stock purchases as attractive opportunities present themselves.

On January 18, 2024, the Company acquired certain intellectual property and technical and marketing information relating to the Speedtracker Mach product line and entered into an asset purchase agreement and a contract manufacturing agreement with RUB Aluminium s.r.o. (“RUB”). The Company acquired the assets using $1 million in cash on hand, with potential additional future cash payments based on successful completion of defined milestones. The initial term of the contract manufacturing agreement is one year, subject to additional one-year renewal terms.

10

The acquisition included transaction costs of $30 thousand for legal fees. Pursuant to the asset purchase agreement, the total earnout payment will be $238 thousand only if the earnout revenue milestone is achieved during the earnout period, otherwise the earnout will be zero. As of June 30, 2024, it was determined that the earnout revenue milestone was unlikely to be achieved during the earnout period and the fair value of the contingent liability was zero. The asset will be amortized on a straight-line basis over a seven-year period.

In some instances, new government contract awards may allow for contract financing in the form of progress payments pursuant to Federal Acquisition Regulation 52.232-16, “Progress Payments.” Subject to certain limitations, this clause provides for government payment of up to 90% of incurred program costs prior to product delivery for small businesses like us. To the extent any contracts allow for progress payments and the respective contracts would result in significant preproduction cash requirements for design, process development, tooling, material or other resources which could exceed our current working capital or line of credit availability, we intend to utilize this benefit to minimize any potential negative impact on working capital prior to receipt of payment for the associated contract deliveries. Currently none of our existing contracts allow for progress payments.

We refer to “ Note 4 – Commitments and Contingencies – Non-cancellable Operating Leases ” for a tabular depiction of our remaining minimum lease and estimated CAM payments under such leases as of June 30, 2024, which disclosure is incorporated herein by reference.

The Company expects to generate net income and positive cash flow from operating activities over the next twelve months. To achieve and retain profitability, we need to maintain a level of revenue adequate to support our cost structure. Management intends to manage operations commensurate with its level of working capital and line of credit during the next twelve months and beyond; however, uneven revenue levels driven by changes in customer delivery demands, first article inspection requirements or other program delays associated with the pandemic, labor shortages and supply chain issues could create a working capital shortfall. In the event the Company does not successfully implement its ultimate business plan, certain assets may not be recoverable.

On March 22, 2023, we entered into a Business Loan Agreement (the “Loan Agreement”) with Texas Capital Bank (the “Lender”), pursuant to which the Lender will make available to the Borrowers a revolving line of credit in the principal amount of $3 million (the “Credit Facility”). The commitment period for advances under the Credit Facility is twenty-six months expiring on May 22, 2025. We refer to the expiration of that time period as the “Maturity Date.” Outstanding advances under the Credit Facility will accrue interest at a rate equal to the secured overnight financing rate (SOFR) plus a specified margin, subject to a specified floor interest rate. The interest rate is currently at 8.07% per annum.

The Loan Agreement contains customary events of default (including a 25% change in ownership) and negative covenants, including but not limited to those governing indebtedness, liens, fundamental changes (including changes in management), investments, and restricted payments (including cash dividends). The Loan Agreement also requires the Borrowers to maintain a fixed charge coverage ratio of at least 1.25:1 and a total leverage ratio of 3.00:1. The Credit Facility is secured by substantially all of the operating assets of the Borrowers as collateral. The Borrowers’ obligations under the Credit Facility are subject to acceleration upon the occurrence of an event of default as defined in the Loan Agreement. The Loan Agreement further provides for a $125,000 Letter of Credit sublimit. As of June 30, 2024, there was $1.0 million borrowed under the Credit Facility. As of June 30, 2024, the Company is in compliance with all covenants under the Credit Facility.

The Credit Facility replaced the prior $2 million line of credit with PNC Bank, National Association.

On September 22, 2021 the Company announced authorization for an additional $1 million stock repurchase program. As of June 30, 2024, there was an authorized balance of $560 thousand remaining to be spent against the repurchase program. During the nine months ended June 30, 2024, there were no stock repurchases against the plan.

11

Critical Accounting Estimates

A critical accounting estimate is an estimate that:

is made in accordance with generally accepted accounting principles,

involves a significant level of estimation uncertainty, and

has had or is reasonably likely to have a material impact on the company’s financial condition or results of operation.

Our significant accounting policies are fundamental to understanding our results of operations and financial condition. Some accounting policies require that we use estimates and assumptions that may affect the value of our assets or liabilities and financial results. These policies are described in “Critical Policies and Accounting Pronouncements” and Note 2 (Accounting Policies) to consolidated financial statements in our Annual Report on Form 10-K for the year ended October 1, 2023.

Our critical accounting estimates include warranty costs, contract losses and the deferred tax asset valuation. Future warranty costs are based on the estimated cost of replacement for expected returns based upon our most recent experience rate of defects as a percentage of warranty covered sales. Our warranty covered sales primarily include the Applied Optics Center optical assemblies. While our warranty period is 12 months, our reserve balances assume a general 90-day return period for optical assemblies previously delivered plus any returned backlog in-house that has not yet been repaired or replaced to our customer. If our actual warranty returns should significantly exceed our historical rates on new customer products, significant production changes, or substantial customer changes to the 90-day turn-around times on returned goods, the impact could be material to our operating profit. We have not experienced any significant changes to our warranty trends in the preceding three years and do not anticipate any significant impacts in the near term. We monitor the actual warranty costs incurred to the expected values on a quarterly basis and adjust our estimates accordingly. As of June 30, 2024, the Company had accrued warranty costs of $36 thousand, as compared to $75 thousand as of October 1, 2023. The primary reason for the $39 thousand decrease in reserve balances relates to lower sales of commercial optical assemblies in combination with improved warranty return trends during the nine-month period.

As of June 30, 2024 and October 1, 2023, we had $101 thousand, and $243 thousand, respectively, of contract loss reserves included in our balance sheet accrued expenses. These loss contracts are related to some of our older legacy periscope IDIQ contracts which were priced in 2018 through early 2020, prior to COVID-19 and the significant downturn in defense spending on ground system vehicles. Due to inflationary price increases on component parts and higher internal manufacturing costs (as a result of escalating labor costs and higher burden rates on reduced volume), some of these contracts are in a loss condition, or at marginal profit rates. These contracts are typically three-year IDIQ contracts with two optional award years, and as such, we are obligated to accept new task awards against these contracts until the contract expiration. One of these long-term contracts has an option year ordering period ending in February 2025 with deliveries that may extend into February 2026. Should contract costs continue to increase above the negotiated selling price, or in the event the customer should release substantial quantities against these existing loss contracts, the losses could be material. For contracts currently in a loss status based on the estimated per unit contract costs, losses are booked immediately on new task order awards. During the three and nine months ended June 30, 2024, the Company recognized a gain on changes in estimates for the contract loss reserves of $16 thousand and $45 thousand and applied reserves of $34 thousand $97 thousand to cost of sales against revenues booked during the periods, respectively. There is no way to reasonably estimate future inflationary impacts, or customer awards on the existing loss contracts.

As of June 30, 2024 and October 1, 2023, the Company had a deferred tax asset valuation allowance of ($0.8) million against deferred tax assets of $1.6 million and $1.7 million, respectively, for a net deferred tax asset of $0.8 million and $0.9 million, respectively. During the nine months ended June 30, 2024, our deferred tax assets decreased by $0.1 million related to temporary tax adjustments. The valuation allowance has been established due to historical losses resulting in a Net Operating Loss Carryforward for each of the fiscal years 2011 through 2016 which may not be fully recognized due to an IRS Section 382 limitation related to a change in control.

12

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not applicable.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, management performed, with the participation of our Principal Executive Officer and Principal Financial Officer, an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s forms, and that such information is accumulated and communicated to our management including our Principal Executive Officer and our Principal Financial Officer, to allow timely decisions regarding required disclosures. Based upon the evaluation described above, our Principal Executive Officer and our Principal Financial Officer concluded that, as of June 30, 2024, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

During the three months ended June 30, 2024, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We are not aware of any material litigation pending or threatened against us.

Item 1A . Risk Factors

There have been no material changes in the risk factors set forth in Form 10-K filed for the year ended October 1, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales

None.

Issuer Purchases of Equity Securities

There were no purchases made by or on behalf of the Company or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) of its common stock under the Exchange Act) during the three months ended June 30, 2024.

Item 3. Defaults upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Not applicable .

Item 5. Other Information.

Not applicable.

13

Item 6. Exhibits

Exhibit No. Description
31.1 and 31.2 Certifications pursuant to Section 302 of Sarbanes Oxley Act of 2002
32.1 and 32.2 Certifications pursuant to Section 906 of Sarbanes Oxley Act of 2002
EX-101.INS Inline XBRL Instance Document
EX-101.SCH Inline XBRL Taxonomy Extension Schema Document
EX-101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
EX-101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
EX-101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

14

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

OPTEX SYSTEMS HOLDINGS, INC.
Date: August 13, 2024 By: /s/ Danny Schoening
Danny Schoening
Principal Executive Officer
OPTEX SYSTEMS HOLDINGS, INC.
Date: August 13, 2024 By: /s/ Karen Hawkins
Karen Hawkins
Principal Financial Officer and
Principal Accounting Officer

15
TABLE OF CONTENTS